SCHEMBL4601538

SCHEMBL4601538

CCCCC(CC)CCC(O)CC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
CA2 P00918 5/20 0.50
TDP1 Q9NUW8 2/20 0.50
CYP3A4 P08684 5/20 0.48
TSHR P16473 4/20 0.48
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPK1 P28482 1/20 0.37
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
HIF1A Q16665 1/20 0.36
CA1 P00915 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14125928 0.93 ALDH1A1 (0.58) ALDH1A1CA2TDP1CYP3A4TSHR
SCHEMBL2989513 0.91 ALDH1A1 (0.56) ALDH1A1CA2TDP1CYP3A4TSHR
SCHEMBL10908012 0.88 ALDH1A1 (0.54) ALDH1A1CA2TDP1CYP3A4TSHR
SCHEMBL14125691 0.86 ALDH1A1 (0.52) ALDH1A1CA2TDP1CYP3A4TSHR
SCHEMBL622136 0.86 ALDH1A1 (0.64) ALDH1A1CA2TDP1CYP3A4TSHR
SCHEMBL5607653 0.85 ALDH1A1 (0.37) ALDH1A1CA2TDP1CYP3A4TSHR
SCHEMBL23673209 0.85 ALDH1A1 (0.50) ALDH1A1CA2TDP1CYP3A4TSHR
SCHEMBL11567202 0.85 ALDH1A1 (0.50) ALDH1A1CA2TDP1CYP3A4TSHR
SCHEMBL524297 0.84 ALDH1A1 (0.65) ALDH1A1CA2TDP1CYP3A4TSHR
SCHEMBL5292674 0.84 ALDH1A1 (0.48) ALDH1A1CA2TDP1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004504370-A 2004-02-12 JP claimed
CN-1440375-A Secondary C10-18 surfactant alcohols BASF AG (DE) 2003-09-03 CN claimed
EP-1303472-A1 SECONDARY C 10- 18 SURFACTANT ALCOHOLS BASF AKTIENGESELLSCHAFT (DE) 2003-04-23 EP claimed
WO-2002008164-A1 SECONDARY C10-18 SURFACTANT ALCOHOLS BASF AKTIENGESELLSCHAFT (DE) 2002-01-31 WO claimed
US-12516147-B2 Aldimines and uses thereof BOSTIK SA (FR) 2026-01-06 US disclosed
EP-4077273-B1 ALDIMINES AND USES THEREOF BOSTIK SA (FR) 2025-04-02 EP disclosed
US-20230038642-A1 ALDIMINES AND USES THEREOF BOSTIK SA (FR) 2023-02-09 US disclosed
EP-4077273-A1 ALDIMINES AND USES THEREOF Bostik SA (FR) 2022-10-26 EP disclosed
WO-2021122594-A1 ALDIMINES AND USES THEREOF BOSTIK SA (FR) 2021-06-24 WO disclosed
EP-3838891-A1 ALDIMINES AND USES THEREOF BOSTIK SA (FR) 2021-06-23 EP disclosed
EP-1878715-B1 Method for obtaining ethanol 3M INNOVATIVE PROPERTIES CO (US) 2013-02-27 EP disclosed
EP-1603855-B1 METHOD FOR OBTAINING ETHANOL 3M INNOVATIVE PROPERTIES CO (US) 2008-04-16 EP disclosed
US-20030176745-A1 Catalytic aldol condensation of C7-C14-aldehydes onto acetone or methyl ethyl ether, hydrogenation; laundry detergents BASF AKTIENGESELLSCHAFT (DE) 2003-09-18 US disclosed
US-20030176745-A1 Catalytic aldol condensation of C7-C14-aldehydes onto acetone or methyl ethyl ether, hydrogenation; laundry detergents BASF AKTIENGESELLSCHAFT (DE) 2003-09-18 US disclosed
CN-1440375-A Secondary C10-18 surfactant alcohols BASF AG (DE) 2003-09-03 CN disclosed
CN-1440375-A Secondary C10-18 surfactant alcohols BASF AG (DE) 2003-09-03 CN disclosed
EP-1303472-A1 SECONDARY C 10- 18 SURFACTANT ALCOHOLS BASF AKTIENGESELLSCHAFT (DE) 2003-04-23 EP disclosed
EP-1303472-A1 SECONDARY C 10- 18 SURFACTANT ALCOHOLS BASF AKTIENGESELLSCHAFT (DE) 2003-04-23 EP disclosed
WO-2002008164-A1 SECONDARY C10-18 SURFACTANT ALCOHOLS BASF AKTIENGESELLSCHAFT (DE) 2002-01-31 WO disclosed
WO-2002008164-A1 SECONDARY C10-18 SURFACTANT ALCOHOLS BASF AKTIENGESELLSCHAFT (DE) 2002-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176745-A1 Catalytic aldol condensation of C7-C14-aldehydes onto acetone or methyl ethyl ether, hydrogenation; laundry detergents ADH1C, DHCR7, LIPC ALDH1A1 700/4885CA2 1278/4885TDP1 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.